North America Proteomics Market

North America Proteomics Market Size (2024 to 2029)

The size of the North American proteomics market is projected to showcase a CAGR of 11% from 2024 to 2029 and this market is estimated at USD 5.78 billion in 2024 and will reach USD 9.74 billion by 2029.

The factor that is significantly contributing to the growth of the North American proteomics market is a rise in the adoption rate of personalized medicines.

The increased number of products in the market is fuelling the growth of the market. Increasing awareness among the people regarding the instruments available in proteomics and their accessibility is driving the growth of the market in the region. Technological advancements are contributing to product innovation and development, which is another significant factor that boosts the growth of the North American proteomics market. The increased adoption rate of proteomics for diagnosing diseases and identifying biomarkers is another major factor contributing to the growth of the proteomics business in North America.The critical factor challenging the growth of the North American proteomics market is the high costs associated with proteomics components. In addition, the lack of skilled and well-experienced professionals in the industry is another factor that is challenging the growth of the proteomics market in North America.

The North American proteomics market is expected to grow significantly during the forecast period and is likely to offer lucrative opportunities for the key players. Increasing the focus of private and research organizations to develop proteomics based on spectrometry is expected to provide lucrative opportunities for the growth of the North American proteomics market. In addition, increasing funding by the governments in the region for research and development activities is supposed to boost growth opportunities for the key players in the market during the forecast period.

This research report on the North American Proteomics Market has been segmented and sub-segmented into the following categories

North America Proteomics Market - By Instrument Type

• Protein Microarrays
• SpectroScopy
• X-ray crystallography
• Chromatography
• Electrophoresis
• Surface Plasmon Resonance
• Protein Fractionation

North America Proteomics Market - By Reagents

• Protein Microarray Reagents
• X-Ray Crystallography Reagents
• Spectroscopy Reagents
• Chromatography Reagents
• Electrophoresis Reagents
• Immunoassay Reagents

North America Proteomics Market - By Software & Service 

• Analytical Laboratory Services
• Data Analysis & Maintenance
• Quantitation Services

North America Proteomics Market - By Application 

• Diagnostics
• Drug Discovery
• Other proteomic Application

North America Proteomics Market - By Country

• The United States
• Canada
• Rest of North America

Regionally, the U.S. proteomics market is predicted to account for the most significant share in the North American proteomics market and is likely to grow at the highest CAGR during the forecast period owing to factors such as the presence of key players in the region, a wide range of applications offered by proteomics, increasing popularity of personalized medicine among patients. The Canadian proteomics market is predicted to have a promising CAGR during the forecast period due to increasing investments from public and private organizations for research and development activities and the availability of technologically advanced products in the market. In addition, the rise in the number of collaborations and novel marketing strategies is further fuelling the growth of the proteomics market in the area.

KEY MARKET PLAYERS

Companies that play a major role in the North American proteomics market profiled in this report are Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, GE Healthcare, and Luminex Merck KGaA, PerkinElmer Inc., Thermo Fisher Scientific, Inc., and Waters Corporation.